Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Allergy and Asthma Reports
Published in: Current Allergy and Asthma Reports 3/2013

01-06-2013 | ALLERGIC AND IMMUNOLOGIC DISORDERS OF THE EYE AND NERVOUS SYSTEM (CH KATELARIS)

Ocular Myositis

Authors: Clare L. Fraser, Simon E. Skalicky, Avinash Gurbaxani, Peter McCluskey

Published in: Current Allergy and Asthma Reports | Issue 3/2013

Login to get access

Abstract

Ocular myositis frequently manifests with orbital pain and diplopia. The diagnosis of ocular myositis falls within the overall classification of idiopathic orbital inflammatory diseases, defined as non-infective non-specific orbital inflammation without identifiable local or systemic causes. Orbital myositis may form part of more widespread systemic inflammatory processes such as Crohn’s disease and the more recently described IgG4-related disease. There is also a broad range of ophthalmic differential diagnoses. Diagnosis, assessment and management of ocular myositis requires the cooperation of ophthalmologists and rheumatologists/immunologists in order to achieve the best patient outcomes. The current literature and avenues of future research are reviewed.
Literature
1.
Gleason J. Idiopathic myositis involving the extraocular muscles. Ophthalmol Rec. 1903;12:471–8.
2.
Fujii H, Fujisada H, Kondo T, et al. Orbital pseudotumor: histopathological classification and treatment. Ophthalmologica. 1985;190(4):230–42.PubMedCrossRef
3.
Mombaerts I, Goldschmeding R, Schlingemann RO, Koornneef L. What is orbital pseudotumor? Surv Ophthalmol. 1996;41(1):66–78.PubMedCrossRef
4.
•• Lindfield D, Attfield K, McElvanney A. Systemic immunoglobulins G4 (IgG4) disease and idiopathic orbital inflammation; removing 'idiopathic' from the nomenclature? Eye. 2012;26(5):623–9. Provides an overview of the current knowledge of IgG4-related disease and orbital inflammatory disease.PubMedCrossRef
5.
Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol. 2003;121(4):491–9.PubMedCrossRef
6.
Yan J, Wu Z, Li Y. A clinical analysis of idiopathic orbital inflammatory pseudotumor. Yan Ke Xue Bao. 2000;16(3):208–13.PubMed
7.
Lacey B, Chang W, Rootman J. Nonthyroid causes of extraocular muscle disease. Surv Ophthalmol. 1999;44(3):187–213.PubMedCrossRef
8.
Schoser BG. Ocular myositis: diagnostic assessment, differential diagnoses, and therapy of a rare muscle disease - five new cases and review. Clin Ophthalmol. 2007;1(1):37–42.PubMed
9.
Culligan B. Orbital myositis following streptococcal pharyngitis in a pediatric patient. Optometry. 2005;76(4):250–8.PubMedCrossRef
10.
Maurer I, Zierz S. Recurrent orbital myositis: report of a familial incidence. Arch Neurol. 1999;56(11):1407–9.PubMedCrossRef
11.
Maalouf T, Trouchaud-Michaud C, Angioi-Duprez K, George JL. What has become of our idiopathic inflammatory pseudo-tumors of the orbit? Orbit. 1999;18(3):157–66.PubMedCrossRef
12.
Yan J, Li Y, Qiu H, et al. Immunohistochemical study of the presence of mast cells in idiopathic orbital inflammatory pseudotumor: possible role of mast cells in the course of its pathogenesis. Int Ophthalmol. 2007;27(4):235–9.PubMedCrossRef
13.
Dalakas MC. Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future. Neuromuscul Disord. 2006;16(4):223–36.PubMedCrossRef
14.
Dalakas MC. Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies. Nat Clin Pract Rheumatol. 2006;2(4):219–27.PubMedCrossRef
15.
Harris GJ. Idiopathic orbital inflammation: a pathogenetic construct and treatment strategy: the 2005 ASOPRS Foundation Lecture. Ophthal Plast Reconstr Surg. 2006;22(2):79–86.PubMedCrossRef
16.
Wallace ZS, Khosroshahi A, Jakobiec FA, et al. IgG4-related systemic disease as a cause of “idiopathic” orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol. 2012;57(1):26–33.PubMedCrossRef
17.
Mannor GE, Rose GE, Moseley IF, Wright JE. Outcome of orbital myositis. Clinical features associated with recurrence. Ophthalmology. 1997;104(3):409–13. discussion, 14.PubMedCrossRef
18.
19.
Browne MA, O'Keefe M, Twomey E, Donoghue V, Ryan S. A case of relapsing flitting bilateral idiopathic orbital inflammation. Pediatr Radiol. 2009;39(12):1361–4.PubMedCrossRef
20.
Stidham DB, Sondhi N, Plager D, Helveston E. Presumed isolated inflammation of the superior oblique muscle in idiopathic orbital myositis. Ophthalmology. 1998;105(12):2216–9.PubMedCrossRef
21.
Nieto JC, Kim N, Lucarelli MJ. Dacryoadenitis and orbital myositis associated with lyme disease. Arch Ophthalmol. 2008;126(8):1165–6.PubMedCrossRef
22.
Krasnianski M, Sievert M, Bau V, Zierz S. External ophthalmoplegia due to ocular myositis in a patient with ophthalmic herpes zoster. Neuromuscul Disord. 2004;14(7):438–41.PubMedCrossRef
23.
Huerva V, Espinet R, Galindo C. Recurrent orbital inflammation and Whipple disease. Ocul Immunol Inflamm. 2008;16(1):37–9.PubMedCrossRef
24.
Kokotis P, Theodossiadis P, Bouros C, Sfikakis PP. Bilateral ocular myositis as a late complication of dermatomyositis. J Rheumatol. 2005;32(2):379–81.PubMed
25.
Attarian S, Fernandez C, Azulay J, et al. Clinical and radiological features and clinical course of orbital myositis. Rev Neurol (Paris). 2003;159(3):307–12.
26.
Raskin EM, McCormick SA, Maher EA, Della Rocca RC. Granulomatous idiopathic orbital inflammation. Ophthal Plast Reconstr Surg. 1995;11(2):131–5.PubMedCrossRef
27.
Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol. 1978;86(5):648–55.PubMed
28.
Culver EL, Salmon JF, Frith P, Travis SP. Recurrent posterior scleritis and orbital myositis as extra-intestinal manifestations of Crohn's disease: case report and systematic literature review. J Crohns Colitis. 2008;2(4):337–42.PubMedCrossRef
29.
Hernandez-Garfella ML, Gracia-Garcia A, Cervera-Taulet E, Garcia-Villanueva C, Montero-Hernandez J. Adalimumab for recurrent orbital myositis in Crohn's disease: report of a case with a 3-year follow-up. J Crohns Colitis. 2011;5(3):265–6.PubMedCrossRef
30.
Pimentel R, Lago P, Pedroto I. Recurrent orbital myositis as an extra-intestinal manifestation of Crohn's disease. J Crohns Colitis. 2012;6(9):958–9.PubMedCrossRef
31.
Bourikas LA, Roussomoustakaki M, Papadaki E, et al. A case of orbital myositis preceding the intestinal symptoms of Crohn's disease. J Crohns Colitis. 2010;4(3):349–50.PubMedCrossRef
32.
Mahr A, Katsahian S, Varet H, et al. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann Rheum Dis. 2012. Sept 8. Epub ahead of print.
33.
Fechner FP, Faquin WC, Pilch BZ. Wegener's granulomatosis of the orbit: a clinicopathological study of 15 patients. Laryngoscope. 2002;112(11):1945–50.PubMedCrossRef
34.
Salam A, Meligonis G, Malhotra R. Superior oblique myositis as an early feature of orbital Wegener's granulomatosis. Orbit. 2008;27(3):203–6.PubMedCrossRef
35.
Stan MN, Garrity JA, Bahn RS. The evaluation and treatment of graves ophthalmopathy. Med Clin North Am. 2012;96(2):311–28.PubMedCrossRef
36.
Seltz LB, Smith J, Durairaj VD, Enzenauer R, Todd J. Microbiology and antibiotic management of orbital cellulitis. Pediatrics. 2011;127(3):e566–72.PubMedCrossRef
37.
Dewan MA, Meyer DR, Wladis EJ. Orbital cellulitis with subperiosteal abscess: demographics and management outcomes. Ophthal Plast Reconstr Surg. 2011;27(5):330–2.PubMedCrossRef
38.
Acharya IG, Jethani J. Pyomyositis of extraocular muscle: case series and review of the literature. Indian J Ophthalmol. 2010;58(6):532–5.PubMedCrossRef
39.
Varma A, Sharma K, Rathi B, Gupta RK, Malik V. Isolated abscess of extraocular muscle in two young boys: clinical and imaging features. Orbit. 2003;22(1):67–72.PubMedCrossRef
40.
Haufschild T, Weber P, Nuttli I, et al. Idiopathic isolated abscess in an extraocular muscle in a child. Arch Ophthalmol. 2004;122(8):1233–4.PubMedCrossRef
41.
Grouteau E, Chaix Y, Armbruster V, et al. Acute orbital myositis and idiopathic inflammatory pseudotumor in children: three cases. Arch Pediatr. 1998;5(2):153–8.PubMedCrossRef
42.
Lutt JR, Lim LL, Phal PM, Rosenbaum JT. Orbital inflammatory disease. Semin Arthritis Rheum. 2008;37(4):207–22.PubMedCrossRef
43.
Capone Jr A, Slamovits TL. Discrete metastasis of solid tumors to extraocular muscles. Arch Ophthalmol. 1990;108(2):237–43.PubMedCrossRef
44.
Kubota T, Kano H. Assessment of inflammation in idiopathic orbital myositis with fat-suppressed T2-weighted magnetic resonance imaging. Am J Ophthalmol. 2007;143(4):718–20.PubMedCrossRef
45.
Frohman LP, Kupersmith MJ, Lang J, et al. Intracranial extension and bone destruction in orbital pseudotumor. Arch Ophthalmol. 1986;104(3):380–4.PubMedCrossRef
46.
Avni-Zauberman N, Tripathy D, Rosen N, Ben Simon GJ. Relapsing migratory idiopathic orbital inflammation: six new cases and review of the literature. Br J Ophthalmol. 2012;96(2):276–80.PubMedCrossRef
47.
Gumus K, Mirza GE, Cavanagh HD, Karakucuk S. Topical cyclosporine A as a steroid-sparing agent in steroid-dependent idiopathic ocular myositis with scleritis: a case report and review of the literature. Eye Contact Lens. 2009;35(5):275–8.PubMedCrossRef
48.
Shah SS, Lowder CY, Schmitt MA, Wilke WS, Kosmorsky GS, Meisler DM. Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology. 1992;99(9):1419–23.PubMed
49.
Magrini L, Rotiroti G, Conti F, et al. Orbital myositis in a patient with primary biliary cirrhosis: successful treatment with methotrexate and corticosteroids. Isr Med Assoc J. 2003;5(11):825–6.PubMed
50.
• Aggarwal R, Oddis C. Therapeutic advances in myositis. Curr Opin Rheumatol. 2012. This is an excellent overview for all types of mysoitis treatments.
51.
Criscione LG, St Clair EW. Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases. Curr Opin Rheumatol. 2002;14(3):204–11.PubMedCrossRef
52.
Garrity JA, Coleman AW, Matteson EL, Eggenberger ER, Waitzman DM. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol. 2004;138(6):925–30.PubMedCrossRef
53.
Lanciano R, Fowble B, Sergott RC, et al. The results of radiotherapy for orbital pseudotumor. Int J Radiat Oncol Biol Phys. 1990;18(2):407–11.PubMedCrossRef
54.
Keleti D, Flickinger JC, Hobson SR, Mittal BB. Radiotherapy of lymphoproliferative diseases of the orbit. Surveillance of 65 cases. Am J Clin Oncol. 1992;15(5):422–7.PubMed
55.
Weinstein GS, Dresner SC, Slamovits TL, Kennerdell JS. Acute and subacute orbital myositis. Am J Ophthalmol. 1983;96(2):209–17.PubMed
56.
• Matthiesen C, Bogardus Jr C, Thompson JS, Farris B, Hildebrand L, Wilkes B, et al. The efficacy of radiotherapy in the treatment of orbital pseudotumor. Int J Radiat Oncol Biol Phys. 2011;79(5):1496–502. Though this is a single-center retrospective review article, it assesses the outcomes of modern radiotherapy treatment in orbital inflammatory disease.PubMedCrossRef
57.
Mombaerts I, Koornneef L. Current status in the treatment of orbital myositis. Ophthalmology. 1997;104(3):402–8.PubMedCrossRef
58.
Isobe K, Uno T, Kawakami H, et al. Radiation therapy for idiopathic orbital myositis: two case reports and literature review. Radiat Med. 2004;22(6):429–31.PubMed
59.
Mombaerts I, Schlingemann RO, Goldschmeding R, Koornneef L. Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology. 1996;103(3):521–8.PubMed
Metadata
Title
Ocular Myositis
Authors
Clare L. Fraser
Simon E. Skalicky
Avinash Gurbaxani
Peter McCluskey
Publication date
01-06-2013
Publisher
Current Science Inc.
Published in
Current Allergy and Asthma Reports / Issue 3/2013
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-012-0319-7

Other articles of this Issue 3/2013

Current Allergy and Asthma Reports 3/2013 Go to the issue

ALLERGENS (RK BUSH, SECTION EDITOR)

What Is the Source of Serum Allergen-Specific IgE?

ALLERGENS (RK BUSH, SECTION EDITOR)

Type 2 Innate Lymphocytes in Allergic Airway Inflammation

ALLERGENS (RK BUSH, SECTION EDITOR)

House Dust Mite Interactions with Airway Epithelium: Role in Allergic Airway Inflammation

ALLERGENS (RK BUSH, SECTION EDITOR)

Airborne Seafood Allergens as a Cause of Occupational Allergy and Asthma

ALLERGENS (RK BUSH, SECTION EDITOR)

Virus/Allergen Interactions in Asthma

Allergic and Immunologic Disorders of the Eye and Nervous System (CH Katelaris, Section Editor)

Use of Cyclosporine A and Tacrolimus in Treatment of Vernal Keratoconjunctivitis